Biomx Company Insiders
PHGE Stock | USD 0.43 0.01 2.27% |
Biomx employs about 52 people. The company is managed by 9 executives with a total tenure of roughly 122 years, averaging almost 13.0 years of service per executive, having 5.78 employees per reported executive. Evaluation of Biomx's management performance can provide insight into the firm performance.
Biomx Management Team Effectiveness
The company has return on total asset (ROA) of (0.366) % which means that it has lost $0.366 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3402) %, meaning that it created substantial loss on money invested by shareholders. Biomx's management efficiency ratios could be used to measure how well Biomx manages its routine affairs as well as how well it operates its assets and liabilities. At present, Biomx's Return On Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Equity is expected to grow to 0.77, whereas Return On Capital Employed is forecasted to decline to (1.17). At present, Biomx's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 169.1 K, whereas Debt To Assets are forecasted to decline to 0.18.The current year's Common Stock Shares Outstanding is expected to grow to about 13.8 B, whereas Net Loss is projected to grow to (31 M).
Biomx Workforce Comparison
Biomx Inc is regarded fourth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 359. Biomx retains roughly 52.0 in number of employees claiming about 14% of equities under Health Care industry.
Biomx Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biomx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biomx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Biomx insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Solomon Jonathan Eitan over a month ago Disposition of 152000 shares by Solomon Jonathan Eitan of Biomx at 7.02 subject to Rule 16b-3 | ||
Assaf Oron over a month ago Acquisition by Assaf Oron of 46966 shares of Biomx at 0.275 subject to Rule 16b-3 | ||
Flynn James E over three months ago Acquisition by Flynn James E of 1611864 shares of Biomx at 0.9306 subject to Rule 16b-3 | ||
Blum Susan over three months ago Disposition of 17600 shares by Blum Susan of Biomx at 0.538 subject to Rule 16b-3 | ||
Assaf Oron over three months ago Disposition of 82667 shares by Assaf Oron of Biomx at 1.973 subject to Rule 16b-3 | ||
Goodman Jesse over three months ago Insider Trading | ||
Merril Gregory Louis over three months ago Insider Trading | ||
Goodman Jesse over six months ago Insider Trading |
Biomx Notable Stakeholders
A Biomx stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biomx often face trade-offs trying to please all of them. Biomx's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biomx's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Marina CPA | CFO Secretary | Profile | |
Jonathan MBA | CEO Director | Profile | |
Assaf Oron | Chief Officer | Profile | |
Eran MD | Scientific Founder | Profile | |
Merav Bassan | Chief Officer | Profile | |
Avraham Gabay | Interim Officer | Profile | |
Pr Sorek | Scientific Founder | Profile | |
Inbar GahaliSass | VP RD | Profile | |
Inbal BenjaminiElran | CHRO | Profile |
About Biomx Management Performance
The success or failure of an entity such as Biomx Inc often depends on how effective the management is. Biomx management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biomx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biomx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.57 | 0.60 | |
Return On Capital Employed | (1.12) | (1.17) | |
Return On Assets | 0.41 | 0.43 | |
Return On Equity | 0.73 | 0.77 |
Please note, the presentation of Biomx's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biomx's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Biomx's management manipulating its earnings.
Biomx Workforce Analysis
Traditionally, organizations such as Biomx use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biomx within its industry.Biomx Manpower Efficiency
Return on Biomx Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 340.9K | |
Net Loss Per Executive | 2M | |
Working Capital Per Employee | 235.6K | |
Working Capital Per Executive | 1.4M |
Complementary Tools for Biomx Stock analysis
When running Biomx's price analysis, check to measure Biomx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomx is operating at the current time. Most of Biomx's value examination focuses on studying past and present price action to predict the probability of Biomx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomx's price. Additionally, you may evaluate how the addition of Biomx to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
CEOs Directory Screen CEOs from public companies around the world | |
Stocks Directory Find actively traded stocks across global markets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |